Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness of the drug Crofelemer in the treatment of non-HIV patients with chronic idiopathic diarrhea; to determine the prevalence of identifiable causes of chronic diarrhea in a non-HIV patients; to assess the diagnostic yield, in terms of identification of treatable etiologies, of commercially available diagnostic evaluations in adult, non-HIV patients with chronic idiopathic diarrhea, that is, evaluate which tests, among the standard diagnostic tests commonly conducted as part of the evaluation of chronic idiopathic diarrhea, are most likely to identify a treatable cause of the diarrhea; and to analyze the relationship between chronic idiopathic diarrhea and health-related quality of life and assess the impact of crofelemer treatment on health-related quality of life.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Chronic Diarrhea of Unknown Origin
  • Diarrhea

NCT number NCT03898856
Study type Interventional
Source The University of Texas Health Science Center, Houston
Contact Brooks Cash, MD
Phone 713-500-6677
Email Brooks.D.Cash@uth.tmc.edu
Status Recruiting
Phase Phase 4
Start date April 1, 2019
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03606031 - Digestive Microbiota Transplant